Celgene Corporation (CELG) Reports First Quarter 2013 Operating and Financial Results
4/25/2013 9:01:51 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Celgene Corporation (NASDAQ: CELG) reported net product sales of $1,429 million for the first quarter of 2013, a 15 percent increase from the same period in 2012. Adjusted net income for the first quarter of 2013 increased 22 percent to $592 million compared to $484 million in the first quarter of 2012. First quarter total revenue was $1,465 million compared to $1,273 million in first quarter of 2012. For the same period, adjusted diluted earnings per share increased 27 percent to $1.37 from $1.08.
Help employers find you! Check out all the jobs and post your resume.